The pharmacogenetics association of CRHR1 gene with response and remission was confirmed in the Sequenced Treatment Alternatives to Relieve Depression, STAR*D cohort, a sample of 1768 MDD patients treated initially by an SSRI (citalopram)16. Here, CRHR1 is linked to depressive symptom measurement.